Cytokines and depression: An analogic approach

Biomedicine and Pharmacotherapy

Volumn 56, Issue 2, 2002, Pages 105-110

  Corcos, M ^a   Guilbaud, O ^a   Hjalmarsson, L ^a   Chambry, J ^a   Jeammet, Ph ^a  

^a INSTITUT MUTUALISTE MONTSOURIS   (France)

Author keywords

Cytokines; Depression; Psychoneuroimmunoendocrinology

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOKINE;

BEHAVIOR; BODY GROWTH; CYTOKINE PRODUCTION; DEPRESSION; HUMAN; IMMUNE DEFICIENCY; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; REVIEW;

EID: 0036128089     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(01)00156-1     Document Type: Note

References (52)

1. Receptors for interleukin-1 (α and β) in mouse brain. Mapping and neuronal localisation in hippocampus
2. Acute phase proteins in major depression
3. Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice
4. Blood levels of cytokines in elderly patients with major depressive disorder
5. Induction of tryptophan degradation in vitro and in vivo: A γ-interferon-stimulated activity
6. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alpha-2b therapy
7. Decreased serum levels of TGFβ associated with major depressive episode in bulimia nervosa
8. Behavioral effects of cytokines: An insight into mechanisms of sickness behavior
9. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone
10. Effects of cytokines on brain catecholamines and indoleamines
11. Serotonin and melatonin synthesis in peripheral blood mononuclear cells: Stimulation by interferon-γ as part of an immunomodulatory pathway
12. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis
13. Elevated levels of acute phase plasma proteins in major depression
14. Plasma concentrations of interleukin-1 beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan
15. Il-1β increases norepinephrine level in rat frontal cortex: Involvement of prostanoids, NO, and glutamate
16. Cytokines and the brain: Implications for clinical psychiatry
17. Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio
18. Cerebrospinal cytokine levels in patients with acute depression
19. The role of inflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection
20. Higher alpha1-antitrypsin, haptoglobulin and ceruloplasmin, and lower retinol binding protein plasma levels during depression: Further evidence for the existence of an inflammatory response during that illness
21. Relationships between interleukin-6 activity, acute phase proteins and HPA-axis function in severe depression
22. Psychosomatic retardation, anorexia, weight loss, sleep disturbances, and loss of energy: Psychopathological correlates of hyperhaptoglobulinemia during major depression
23. Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression
24. Interleukin-1 beta: A putative mediator of HPA axis hyperactivity in depression?
25. Evidence for an immune response in major depression: A review and hypothesis
26. Total serum protein and serum protein fractions in depression: Relationships to depressive symptoms and glucocorticoid activity
27. Increased plasma concentrations of interleukin-6, soluble interleukin-2, and transferrin receptor in major depression
28. Increased serum soluble CD8 or suppressor/cytotoxic antigen concentrations in depression: Suppressive effects of glucocorticoids
29. Increased serum Il-6 and Il-1 receptor antagonist concentrations in major depression and treatment resistant depression
30. Negative immunoregulatory effects of antidepressants: Inhibition of interferon-gamma and stimulation of interleukin-10 secretion
31. Leukocytosis induced by microinjection of endogenous pyrogen or interleukin-1 into the preoptic and anterior hypothalamus
32. Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders
33. Paroxetine for the prevention of the depression and neurotoxicity induced by high dose interferon-alpha therapy
34. Alpha1-acid glycoprotein in major depressive disorder. Relationship to severity, response to treatment and imipramine plasma levels
35. Raised levels of plasma interleukin-1beta in major and postviral depression
36. Anorexia during acute and chronic disease: Relevance of neurotransmitter-peptide-cytokine interactions
37. Regulation of the human serotonin transporter by interleukin-1 beta
38. Cytokines and the nervous system II: Actions and mechanisms of action
39. Inflammatory markers in major depression and melancholia
40. Cytokine production and serum proteins in depression
41. Hypothalamic and thalamic sites of action of interleukin-1β on food intake, body temperature and pain sensitivity in the rat
42. Hippocampal atrophy in recurrent major depression
43. Indicators of immune activation in major depression
44. Changes in immunoglobulin, complement and acute phase protein levels in depressed patients and normal controls
45. Interleukin-6 and the soluble Il-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: No alteration of soluble gp130
46. Mood and cognitive side effects of interferon-alpha therapy
47. Activation of the inflammatory response system: A new look at the etiopathogenesis of major depression
48. Interleukin (Il) 1β, Il-1 receptor antagonist, Il-10, and Il-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: Pathophysiological implications
49. Behavioral and psychological effects of immune activation: Implications for depression due to general medical condition
50. Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice
51. The relationship of depression and stressors to immunological assays: A meta-analytic review